BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190523
DTSTAMP:20260514T223708
CREATED:20190108T102413Z
LAST-MODIFIED:20190108T102413Z
UID:18964-1558310400-1558569599@www.pharmajournalist.com
SUMMARY:Microbiome & Probiotics Series: Europe
DESCRIPTION:Part of the leading global microbiome and probiotics conference series\, the 2019 European event will bring together more than 400 industry\, academic\, and investment leaders to discuss the must cutting-edge microbiome and probiotics research\, challenges and opportunities in moving research towards commercialisation\, and potential partnerships and collaborations. \nFor the first time\, this event will be three days. As an attendee\, you will get more in-depth content on the key challenges and topics facing researchers and product developers\, and more time to establish partnerships. Hear from top scientists in the field\, meet willing investors and collaborators\, and learn about exciting new companies in the microbiome space. With ample networking time and interactive sessions like the roundtable discussions\, there will be many opportunities to broaden your connections.
URL:https://www.pharmajournalist.com/event/microbiome-probiotics-series-europe/
LOCATION:Rotterdam\, The Netherlands Postilion Convention Centre WTC Rotterdam\, Rotterdam\, Netherlands
ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190523
DTSTAMP:20260514T223708
CREATED:20190108T102702Z
LAST-MODIFIED:20190108T102702Z
UID:18969-1558310400-1558569599@www.pharmajournalist.com
SUMMARY:Plant Genomics and Gene Editing Congress: Europe
DESCRIPTION:Global Engage is pleased to announce the 7th Plant Genomics & Gene Editing Congress: Europe\, taking place 21st-22nd May 2019\, in Rotterdam\, The Netherlands. This event is part of our widely-regarded Plant Genomics Series which includes an Asian and US meeting each year. \nAttracting over 300 experts working in all areas of plant science\, this event will examine the latest in gene editing methods for plant genomics research. CRISPR/Cas9 case studies and the very best strategies for plant genome engineering will be presented by industry leaders\, experts\, and pioneering academics at the forefront of plant research. Developments in gene editing\, NGS\, and omic technologies will all be explored for crop trait development\, disease resistance\, epigenetics\, plant breeding\, and more. Tracks dedicated to plant & soil microbiomes\, and the importance of plant phenotyping in the context of bioinformatics challenges\, will encourage a holistic approach to plant research; the former will focus on identifying microbes to enhance crop productivity & disease resistance\, while the latter will showcase the best tools for overcoming bioinformatics bottlenecks\, applicable to plant research across the board. We will also be looking to examine the impact of the ECJ’s latest interpretation of GMO regulations\, and what this means for the future of gene editing research\, addressing issues such as how to navigate the new legislation\, and considering what alternative strategies & technologies there might be for progressing plant genomics.
URL:https://www.pharmajournalist.com/event/plant-genomics-and-gene-editing-congress-europe/
LOCATION:Rotterdam\, The Netherlands Postilion Convention Centre WTC Rotterdam\, Rotterdam\, Netherlands
ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190524
DTSTAMP:20260514T223708
CREATED:20190213T092120Z
LAST-MODIFIED:20190214T153920Z
UID:19511-1558310400-1558655999@www.pharmajournalist.com
SUMMARY:TIDES: Oligonucleotide & Peptide Therapeutics
DESCRIPTION:TIDES is the world’s largest meeting to accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization. \n \n1000+ Oligonucleotide & Peptide Scientists and Executives\nFast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma\, biotechs\, academia and solution providers from North America\, Asia and Europe. \n90+ Exhibitors\nConnect with leading manufacturing\, technologies\, and service providers to drive your promising therapeutic towards commercial success. \n125+ Case Studies and New Data Presentations\nHear best practices\, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production. \nRegister now at www.TIDESEvent.com with code “PHARMJ10” and SAVE 10%.
URL:https://www.pharmajournalist.com/event/tides-oligonucleotide-peptide-therapeutics/
LOCATION:Manchester Grand Hyatt | San Diego\, CA
ORGANIZER;CN="Knect365 Life Sciences":MAILTO:Allison.macdonald@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190521
DTEND;VALUE=DATE:20190523
DTSTAMP:20260514T223708
CREATED:20181214T110222Z
LAST-MODIFIED:20181214T110356Z
UID:18840-1558396800-1558569599@www.pharmajournalist.com
SUMMARY:3rd Annual Digi-Tech Pharma 2019
DESCRIPTION:Our upcoming conference 3rd Annual Digi-Tech Pharma 2019 (Pharmaceutical technology conference 2019)\, will provide a platform to all its participants an opportunity to interact\, share and discuss the digitalization of Pharma industry. The conference will allow its participants to discuss the various challenges faced\, new strategies\, case studies and use of innovative ideas in the field of Digital Pharma IT. Also\, to stay updated on the latest trends in digital\, social media and mobile strategies required to overcome the obstructions in the transformation. This Digi-Tech Pharma 2019 is a unique platform in the pharmaceutical conferences which will allow IT leaders to share their technologies and strategies to help the pharma industries avail new opportunities to encourage partnerships and collaborations.
URL:https://www.pharmajournalist.com/event/3rd-annual-digi-tech-pharma-2019/
LOCATION:London\, United Kingdom
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190521
DTEND;VALUE=DATE:20190524
DTSTAMP:20260514T223708
CREATED:20190206T125335Z
LAST-MODIFIED:20190206T125335Z
UID:19387-1558396800-1558655999@www.pharmajournalist.com
SUMMARY:NDD Europe 2019
DESCRIPTION:Overcome Translational Challenges Preventing the Development of Clinically Effective Neurodegenerative Therapeutics \n \nMultiple clinical failures in the neurodegenerative field have sparked realisation that there is a critical need for discussion and debate between neurodegenerative drug developers to drive clinical success. \nNDD Europe will overcome the translational challenges facing neurodegenerative drug developers by exploring the future biomarkers of neurodegeneration\, improving preclinical modelling to increase clinical predictability and encouraging precompetitive strategies and collaboration amongst drug developers. \nWith 70+ thought-leaders converging at NDD Europe\, this will be an unrivalled opportunity for you to gain the latest scientific insights\, have your peers review your research and grow your collaborator network.
URL:https://www.pharmajournalist.com/event/ndd-europe-2019/
LOCATION:Hilton Paris La Defense\, 2 Place de la Défense\, 92800\, Puteaux\, France\, France
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190521
DTEND;VALUE=DATE:20190524
DTSTAMP:20260514T223708
CREATED:20190404T072211Z
LAST-MODIFIED:20190404T072453Z
UID:20182-1558396800-1558655999@www.pharmajournalist.com
SUMMARY:5th Precision CRISPR Genome Editing Congress
DESCRIPTION:Designed with CRISPR experts from AstraZeneca\, AbbVie\, Broad Institute\, Casebia\, Merck\, Amgen and academics worldwide\, this years 5th Precision CRISPR Genome Editing Congress encapsulates the critical scientific challenges and opportunities of CRISPR applications with regards to delivery\, safety\, precision\, and efficiency to further optimize the relevant areas of drug discovery\, functional screening & CRISPR-based cell & gene therapy. \n \n\nLearn about how CRISPR is working in a clinical setting and unique approaches to gene therapy\nDiscover advances in disease modeling and strategies improving validation of human biology\nUnderstand how we are harnessing novel CRISPR systems and the resulting expansion of the molecular toolbox\nExplore how base editing is set to be the best technique for precision genome editing and the consequent applications in both basic biology and genetic diseases\nDiscover the wealth of CRISPR screening techniques available and how to implement them into your own drug discovery pipeline\nParticipate in forward-thinking debates and discussions crucial to advancing the infinite possibilities of CRISPR\n\nWith 100+ thought-leaders converging\, this will surely be an unrivaled opportunity for you to gain the latest scientific insights into the ever-evolving CRISPR landscape and grow your collaborator network. \nTo learn more about this event\, visit https://ter.li/tjkmgn
URL:https://www.pharmajournalist.com/event/5th-precision-crispr-genome-editing-congress/
LOCATION:The Westin Boston Waterfront\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR